JPMorgan Chase & Co. Increases Position in Doximity, Inc. (NASDAQ:DOCS)

JPMorgan Chase & Co. raised its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 3.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 498,056 shares of the company's stock after purchasing an additional 15,771 shares during the quarter. JPMorgan Chase & Co. owned about 0.27% of Doximity worth $21,700,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. MetLife Investment Management LLC grew its holdings in shares of Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company's stock valued at $2,835,000 after buying an additional 363 shares during the last quarter. First Horizon Advisors Inc. grew its stake in Doximity by 22.5% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company's stock valued at $91,000 after purchasing an additional 384 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock valued at $63,000 after purchasing an additional 412 shares during the period. Cornercap Investment Counsel Inc. raised its stake in shares of Doximity by 3.2% in the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company's stock worth $479,000 after purchasing an additional 537 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in shares of Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after purchasing an additional 603 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Price Performance

DOCS stock traded down $0.55 during trading on Thursday, hitting $54.93. The stock had a trading volume of 1,323,995 shares, compared to its average volume of 1,381,719. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75. The company's 50-day moving average price is $52.88 and its two-hundred day moving average price is $41.42. The stock has a market capitalization of $10.25 billion, a P/E ratio of 63.14, a PEG ratio of 4.16 and a beta of 1.38.

Analysts Set New Price Targets

DOCS has been the topic of several research reports. Mizuho initiated coverage on shares of Doximity in a report on Wednesday, December 4th. They issued a "neutral" rating and a $55.00 price target on the stock. Baird R W raised shares of Doximity to a "strong-buy" rating in a report on Tuesday, September 17th. Morgan Stanley raised shares of Doximity from an "underweight" rating to an "equal weight" rating and upped their price target for the company from $33.00 to $53.00 in a report on Thursday, November 14th. The Goldman Sachs Group started coverage on Doximity in a research report on Friday, November 15th. They set a "neutral" rating and a $58.00 price target on the stock. Finally, Wells Fargo & Company raised Doximity from an "underweight" rating to an "equal weight" rating and boosted their price objective for the company from $19.00 to $41.00 in a report on Friday, November 8th. Thirteen equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Doximity presently has a consensus rating of "Hold" and a consensus price target of $53.00.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.